nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—TOP2A—hematologic cancer	0.215	0.779	CbGaD
Levofloxacin—ABCB1—hematologic cancer	0.0611	0.221	CbGaD
Levofloxacin—TOP2A—Idarubicin—hematologic cancer	0.0551	0.115	CbGbCtD
Levofloxacin—TOP2A—Daunorubicin—hematologic cancer	0.039	0.0815	CbGbCtD
Levofloxacin—TOP2A—Teniposide—hematologic cancer	0.0338	0.0708	CbGbCtD
Levofloxacin—TOP2A—Mitoxantrone—hematologic cancer	0.0237	0.0495	CbGbCtD
Levofloxacin—SLC22A2—Daunorubicin—hematologic cancer	0.0196	0.041	CbGbCtD
Levofloxacin—TOP2A—Epirubicin—hematologic cancer	0.0192	0.0401	CbGbCtD
Levofloxacin—SLC22A2—Cytarabine—hematologic cancer	0.0173	0.0361	CbGbCtD
Levofloxacin—SLC22A2—Cladribine—hematologic cancer	0.0163	0.0341	CbGbCtD
Levofloxacin—SLC22A2—Imatinib—hematologic cancer	0.015	0.0314	CbGbCtD
Levofloxacin—TOP2A—Etoposide—hematologic cancer	0.0149	0.0312	CbGbCtD
Levofloxacin—CYP1A2—Anagrelide—hematologic cancer	0.0147	0.0307	CbGbCtD
Levofloxacin—TOP2A—Doxorubicin—hematologic cancer	0.0102	0.0213	CbGbCtD
Levofloxacin—ABCB1—Lenalidomide—hematologic cancer	0.00889	0.0186	CbGbCtD
Levofloxacin—SLC22A2—Vinblastine—hematologic cancer	0.00833	0.0174	CbGbCtD
Levofloxacin—CYP1A2—Carmustine—hematologic cancer	0.0077	0.0161	CbGbCtD
Levofloxacin—SLC22A2—Cisplatin—hematologic cancer	0.00763	0.016	CbGbCtD
Levofloxacin—CYP1A2—Methoxsalen—hematologic cancer	0.00655	0.0137	CbGbCtD
Levofloxacin—CYP1A2—Bortezomib—hematologic cancer	0.00623	0.013	CbGbCtD
Levofloxacin—CYP1A2—Daunorubicin—hematologic cancer	0.00596	0.0125	CbGbCtD
Levofloxacin—CYP1A2—Alitretinoin—hematologic cancer	0.00584	0.0122	CbGbCtD
Levofloxacin—CYP1A2—Thalidomide—hematologic cancer	0.00543	0.0114	CbGbCtD
Levofloxacin—CYP3A4—Bexarotene—hematologic cancer	0.00532	0.0111	CbGbCtD
Levofloxacin—ABCB1—Daunorubicin—hematologic cancer	0.00521	0.0109	CbGbCtD
Levofloxacin—ABCB1—Alitretinoin—hematologic cancer	0.0051	0.0107	CbGbCtD
Levofloxacin—CYP3A4—Lomustine—hematologic cancer	0.00495	0.0104	CbGbCtD
Levofloxacin—CYP3A4—Busulfan—hematologic cancer	0.00495	0.0104	CbGbCtD
Levofloxacin—CYP1A2—Dacarbazine—hematologic cancer	0.00467	0.00977	CbGbCtD
Levofloxacin—CYP1A2—Imatinib—hematologic cancer	0.00456	0.00955	CbGbCtD
Levofloxacin—CYP3A4—Thiotepa—hematologic cancer	0.00441	0.00923	CbGbCtD
Levofloxacin—ABCB1—Imatinib—hematologic cancer	0.00399	0.00835	CbGbCtD
Levofloxacin—CYP1A2—Dasatinib—hematologic cancer	0.00367	0.00767	CbGbCtD
Levofloxacin—ABCB1—Nilotinib—hematologic cancer	0.00363	0.00759	CbGbCtD
Levofloxacin—ABCB1—Vinorelbine—hematologic cancer	0.0036	0.00753	CbGbCtD
Levofloxacin—CYP3A4—Methoxsalen—hematologic cancer	0.00343	0.00718	CbGbCtD
Levofloxacin—CYP3A4—Bortezomib—hematologic cancer	0.00326	0.00683	CbGbCtD
Levofloxacin—ABCB1—Dasatinib—hematologic cancer	0.00321	0.00671	CbGbCtD
Levofloxacin—ABCB1—Mitoxantrone—hematologic cancer	0.00317	0.00663	CbGbCtD
Levofloxacin—CYP3A4—Daunorubicin—hematologic cancer	0.00312	0.00653	CbGbCtD
Levofloxacin—SLC22A6—Methotrexate—hematologic cancer	0.00296	0.0062	CbGbCtD
Levofloxacin—ABCB1—Betamethasone—hematologic cancer	0.00282	0.00591	CbGbCtD
Levofloxacin—ABCB1—Gemcitabine—hematologic cancer	0.0028	0.00585	CbGbCtD
Levofloxacin—ABCB1—Prednisolone—hematologic cancer	0.00278	0.00583	CbGbCtD
Levofloxacin—CYP3A4—Cytarabine—hematologic cancer	0.00275	0.00576	CbGbCtD
Levofloxacin—CYP3A4—Teniposide—hematologic cancer	0.00271	0.00568	CbGbCtD
Levofloxacin—ABCB1—Prednisone—hematologic cancer	0.00263	0.0055	CbGbCtD
Levofloxacin—CYP3A4—Ifosfamide—hematologic cancer	0.0025	0.00524	CbGbCtD
Levofloxacin—ABCB1—Irinotecan—hematologic cancer	0.00249	0.00522	CbGbCtD
Levofloxacin—CYP3A4—Imatinib—hematologic cancer	0.00239	0.005	CbGbCtD
Levofloxacin—CYP1A2—Etoposide—hematologic cancer	0.00228	0.00478	CbGbCtD
Levofloxacin—CYP3A4—Ruxolitinib—hematologic cancer	0.00225	0.00471	CbGbCtD
Levofloxacin—ABCB1—Vinblastine—hematologic cancer	0.00222	0.00464	CbGbCtD
Levofloxacin—ABCB1—Vincristine—hematologic cancer	0.00218	0.00456	CbGbCtD
Levofloxacin—CYP3A4—Nilotinib—hematologic cancer	0.00217	0.00455	CbGbCtD
Levofloxacin—CYP3A4—Vinorelbine—hematologic cancer	0.00215	0.00451	CbGbCtD
Levofloxacin—ABCB1—Cisplatin—hematologic cancer	0.00203	0.00425	CbGbCtD
Levofloxacin—ABCB1—Etoposide—hematologic cancer	0.002	0.00418	CbGbCtD
Levofloxacin—CYP3A4—Triamcinolone—hematologic cancer	0.00197	0.00412	CbGbCtD
Levofloxacin—CYP3A4—Dasatinib—hematologic cancer	0.00192	0.00402	CbGbCtD
Levofloxacin—CYP3A4—Mitoxantrone—hematologic cancer	0.0019	0.00397	CbGbCtD
Levofloxacin—CYP3A4—Betamethasone—hematologic cancer	0.00169	0.00354	CbGbCtD
Levofloxacin—CYP3A4—Prednisolone—hematologic cancer	0.00167	0.00349	CbGbCtD
Levofloxacin—ABCB1—Dexamethasone—hematologic cancer	0.00164	0.00344	CbGbCtD
Levofloxacin—CYP3A4—Prednisone—hematologic cancer	0.00158	0.0033	CbGbCtD
Levofloxacin—CYP3A4—Irinotecan—hematologic cancer	0.00149	0.00313	CbGbCtD
Levofloxacin—ABCB1—Doxorubicin—hematologic cancer	0.00136	0.00285	CbGbCtD
Levofloxacin—CYP3A4—Vinblastine—hematologic cancer	0.00133	0.00278	CbGbCtD
Levofloxacin—ABCB1—Methotrexate—hematologic cancer	0.00132	0.00276	CbGbCtD
Levofloxacin—CYP3A4—Vincristine—hematologic cancer	0.00131	0.00273	CbGbCtD
Levofloxacin—CYP3A4—Etoposide—hematologic cancer	0.0012	0.0025	CbGbCtD
Levofloxacin—CYP3A4—Dexamethasone—hematologic cancer	0.000983	0.00206	CbGbCtD
Levofloxacin—CYP3A4—Doxorubicin—hematologic cancer	0.000816	0.00171	CbGbCtD
Levofloxacin—Moxifloxacin—TOP2A—hematologic cancer	0.000535	0.186	CrCbGaD
Levofloxacin—Pefloxacin—TOP2A—hematologic cancer	0.00039	0.136	CrCbGaD
Levofloxacin—Enoxacin—TOP2A—hematologic cancer	0.000365	0.127	CrCbGaD
Levofloxacin—Sparfloxacin—TOP2A—hematologic cancer	0.000336	0.117	CrCbGaD
Levofloxacin—Lomefloxacin—TOP2A—hematologic cancer	0.000277	0.0963	CrCbGaD
Levofloxacin—Ofloxacin—TOP2A—hematologic cancer	0.000236	0.0823	CrCbGaD
Levofloxacin—Ciprofloxacin—TOP2A—hematologic cancer	0.000228	0.0795	CrCbGaD
Levofloxacin—TOP2A—Nilotinib—Imatinib—hematologic cancer	0.000228	0.0778	CbGdCrCtD
Levofloxacin—Norfloxacin—TOP2A—hematologic cancer	0.000192	0.0667	CrCbGaD
Levofloxacin—Gatifloxacin—ALB—hematologic cancer	0.000153	0.0534	CrCbGaD
Levofloxacin—TOP2A—Topotecan—Irinotecan—hematologic cancer	0.000127	0.0432	CbGdCrCtD
Levofloxacin—TOP2A—Etoposide—Teniposide—hematologic cancer	0.000126	0.0429	CbGdCrCtD
Levofloxacin—TOP2A—Vindesine—Vinorelbine—hematologic cancer	0.000113	0.0386	CbGdCrCtD
Levofloxacin—TOP2A—Podofilox—Teniposide—hematologic cancer	9.59e-05	0.0327	CbGdCrCtD
Levofloxacin—Sparfloxacin—ABCB1—hematologic cancer	9.55e-05	0.0332	CrCbGaD
Levofloxacin—TOP2A—Vindesine—Vinblastine—hematologic cancer	9.05e-05	0.0308	CbGdCrCtD
Levofloxacin—TOP2A—Vindesine—Vincristine—hematologic cancer	9.05e-05	0.0308	CbGdCrCtD
Levofloxacin—TOP2A—Floxuridine—Pentostatin—hematologic cancer	8.72e-05	0.0297	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	8.55e-05	0.0291	CbGdCrCtD
Levofloxacin—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	8.55e-05	0.0291	CbGdCrCtD
Levofloxacin—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	8.55e-05	0.0291	CbGdCrCtD
Levofloxacin—TOP2A—Menadione—Thalidomide—hematologic cancer	7.27e-05	0.0248	CbGdCrCtD
Levofloxacin—TOP2A—Cladribine—Pentostatin—hematologic cancer	6.6e-05	0.0225	CbGdCrCtD
Levofloxacin—Ciprofloxacin—ABCB1—hematologic cancer	6.49e-05	0.0226	CrCbGaD
Levofloxacin—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	6.48e-05	0.0221	CbGdCrCtD
Levofloxacin—TOP2A—Epirubicin—Idarubicin—hematologic cancer	6.48e-05	0.0221	CbGdCrCtD
Levofloxacin—TOP2A—Doxorubicin—Idarubicin—hematologic cancer	6.48e-05	0.0221	CbGdCrCtD
Levofloxacin—TOP2A—Vincristine—Vinorelbine—hematologic cancer	6.1e-05	0.0208	CbGdCrCtD
Levofloxacin—TOP2A—Cladribine—Clofarabine—hematologic cancer	5.88e-05	0.0201	CbGdCrCtD
Levofloxacin—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	5.71e-05	0.0195	CbGdCrCtD
Levofloxacin—TOP2A—Vinorelbine—Vincristine—hematologic cancer	5.71e-05	0.0195	CbGdCrCtD
Levofloxacin—TOP2A—Teniposide—Etoposide—hematologic cancer	5.7e-05	0.0194	CbGdCrCtD
Levofloxacin—TOP2A—Podofilox—Etoposide—hematologic cancer	5.7e-05	0.0194	CbGdCrCtD
Levofloxacin—TOP2A—Cladribine—Nelarabine—hematologic cancer	5.53e-05	0.0189	CbGdCrCtD
Levofloxacin—TOP2A—Floxuridine—Cladribine—hematologic cancer	5.25e-05	0.0179	CbGdCrCtD
Levofloxacin—TOP2A—Clofarabine—Nelarabine—hematologic cancer	5.11e-05	0.0174	CbGdCrCtD
Levofloxacin—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	4.91e-05	0.0167	CbGdCrCtD
Levofloxacin—TOP2A—Vincristine—Vinblastine—hematologic cancer	4.88e-05	0.0166	CbGdCrCtD
Levofloxacin—TOP2A—Cytarabine—Clofarabine—hematologic cancer	4.63e-05	0.0158	CbGdCrCtD
Levofloxacin—TOP2A—Cytarabine—Nelarabine—hematologic cancer	4.35e-05	0.0148	CbGdCrCtD
Levofloxacin—TOP2A—Cladribine—Fludarabine—hematologic cancer	4.32e-05	0.0147	CbGdCrCtD
Levofloxacin—TOP2A—Clofarabine—Fludarabine—hematologic cancer	3.99e-05	0.0136	CbGdCrCtD
Levofloxacin—TOP2A—Vinblastine—Vincristine—hematologic cancer	3.92e-05	0.0134	CbGdCrCtD
Levofloxacin—TOP2A—Clofarabine—Cytarabine—hematologic cancer	3.77e-05	0.0129	CbGdCrCtD
Levofloxacin—TOP2A—Azacitidine—Pentostatin—hematologic cancer	3.72e-05	0.0127	CbGdCrCtD
Levofloxacin—TOP2A—Clofarabine—Cladribine—hematologic cancer	3.67e-05	0.0125	CbGdCrCtD
Levofloxacin—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	3.49e-05	0.0119	CbGdCrCtD
Levofloxacin—TOP2A—Cytarabine—Fludarabine—hematologic cancer	3.4e-05	0.0116	CbGdCrCtD
Levofloxacin—TOP2A—Azacitidine—Clofarabine—hematologic cancer	3.32e-05	0.0113	CbGdCrCtD
Levofloxacin—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	3.21e-05	0.0109	CbGdCrCtD
Levofloxacin—TOP2A—Azacitidine—Nelarabine—hematologic cancer	3.12e-05	0.0106	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Epirubicin—hematologic cancer	2.97e-05	0.0101	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	2.97e-05	0.0101	CbGdCrCtD
Levofloxacin—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	2.97e-05	0.0101	CbGdCrCtD
Levofloxacin—TOP2A—blood—hematologic cancer	2.85e-05	0.0891	CbGeAlD
Levofloxacin—TOP2A—bone marrow—hematologic cancer	2.76e-05	0.0862	CbGeAlD
Levofloxacin—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	2.75e-05	0.00938	CbGdCrCtD
Levofloxacin—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	2.75e-05	0.00938	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Doxorubicin—hematologic cancer	2.75e-05	0.00938	CbGdCrCtD
Levofloxacin—TOP2A—lung—hematologic cancer	2.5e-05	0.0781	CbGeAlD
Levofloxacin—TOP2A—Azacitidine—Fludarabine—hematologic cancer	2.44e-05	0.0083	CbGdCrCtD
Levofloxacin—TOP2A—testis—hematologic cancer	2.36e-05	0.0737	CbGeAlD
Levofloxacin—TOP2A—Azacitidine—Cytarabine—hematologic cancer	2.3e-05	0.00784	CbGdCrCtD
Levofloxacin—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	2.3e-05	0.00784	CbGdCrCtD
Levofloxacin—SLC22A4—blood—hematologic cancer	2.28e-05	0.0713	CbGeAlD
Levofloxacin—TOP2A—Azacitidine—Cladribine—hematologic cancer	2.24e-05	0.00764	CbGdCrCtD
Levofloxacin—SLC22A4—bone marrow—hematologic cancer	2.21e-05	0.069	CbGeAlD
Levofloxacin—CYP1A2—hematopoietic system—hematologic cancer	2.06e-05	0.0645	CbGeAlD
Levofloxacin—SLC22A4—lung—hematologic cancer	2e-05	0.0625	CbGeAlD
Levofloxacin—TOP2A—lymph node—hematologic cancer	1.71e-05	0.0534	CbGeAlD
Levofloxacin—CYP3A4—hematopoietic system—hematologic cancer	1.49e-05	0.0467	CbGeAlD
Levofloxacin—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	1.37e-05	0.00468	CbGdCrCtD
Levofloxacin—SLC22A4—lymph node—hematologic cancer	1.37e-05	0.0427	CbGeAlD
Levofloxacin—CYP1A2—blood—hematologic cancer	1.37e-05	0.0427	CbGeAlD
Levofloxacin—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	1.34e-05	0.00457	CbGdCrCtD
Levofloxacin—CYP1A2—lung—hematologic cancer	1.2e-05	0.0375	CbGeAlD
Levofloxacin—ABCB1—hematopoietic system—hematologic cancer	1.06e-05	0.033	CbGeAlD
Levofloxacin—CYP3A4—blood—hematologic cancer	9.9e-06	0.0309	CbGeAlD
Levofloxacin—CYP1A2—Metabolism—SMPD3—hematologic cancer	9.57e-06	0.000231	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	9.55e-06	0.00023	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	9.54e-06	0.00023	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	9.5e-06	0.000229	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	9.47e-06	0.000229	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—UGT1A1—hematologic cancer	9.36e-06	0.000226	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDKN1A—hematologic cancer	9.36e-06	0.000226	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SLC22A1—hematologic cancer	9.11e-06	0.00022	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CRABP1—hematologic cancer	9.11e-06	0.00022	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CDA—hematologic cancer	9.08e-06	0.000219	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	9.03e-06	0.000218	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	8.92e-06	0.000215	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	8.92e-06	0.000215	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—EP300—hematologic cancer	8.91e-06	0.000215	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ALOX5—hematologic cancer	8.88e-06	0.000214	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PC—hematologic cancer	8.74e-06	0.000211	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	8.69e-06	0.00021	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—hematologic cancer	8.68e-06	0.00021	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.67e-06	0.000209	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NUP98—hematologic cancer	8.6e-06	0.000208	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	8.58e-06	0.000207	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	8.45e-06	0.000204	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GBA—hematologic cancer	8.44e-06	0.000204	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC35B2—hematologic cancer	8.44e-06	0.000204	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	8.44e-06	0.000204	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—B3GAT1—hematologic cancer	8.36e-06	0.000202	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ASNS—hematologic cancer	8.36e-06	0.000202	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—DCK—hematologic cancer	8.36e-06	0.000202	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ADCY7—hematologic cancer	8.35e-06	0.000201	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NCOA3—hematologic cancer	8.35e-06	0.000201	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NUP214—hematologic cancer	8.29e-06	0.0002	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—HRAS—hematologic cancer	8.18e-06	0.000197	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	8.17e-06	0.000197	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—MTR—hematologic cancer	8.12e-06	0.000196	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ABCG2—hematologic cancer	8.12e-06	0.000196	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	8.12e-06	0.000196	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—FTCD—hematologic cancer	8.07e-06	0.000195	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PHYH—hematologic cancer	8.07e-06	0.000195	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GMPS—hematologic cancer	8.07e-06	0.000195	CbGpPWpGaD
Levofloxacin—ABCB1—gonad—hematologic cancer	8.04e-06	0.0251	CbGeAlD
Levofloxacin—TOP2A—Cell Cycle—MAPK3—hematologic cancer	7.98e-06	0.000193	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ENO2—hematologic cancer	7.96e-06	0.000192	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—HDC—hematologic cancer	7.93e-06	0.000191	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MYC—hematologic cancer	7.76e-06	0.000187	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—MTAP—hematologic cancer	7.72e-06	0.000186	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTT1—hematologic cancer	7.72e-06	0.000186	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	7.72e-06	0.000186	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	7.56e-06	0.000183	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SDC1—hematologic cancer	7.55e-06	0.000182	CbGpPWpGaD
Levofloxacin—Feeling abnormal—Betamethasone—hematologic cancer	7.46e-06	3.76e-05	CcSEcCtD
Levofloxacin—Flushing—Doxorubicin—hematologic cancer	7.45e-06	3.75e-05	CcSEcCtD
Levofloxacin—Cardiac disorder—Doxorubicin—hematologic cancer	7.45e-06	3.75e-05	CcSEcCtD
Levofloxacin—Flatulence—Epirubicin—hematologic cancer	7.45e-06	3.75e-05	CcSEcCtD
Levofloxacin—Tension—Epirubicin—hematologic cancer	7.42e-06	3.73e-05	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.4e-06	3.73e-05	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Betamethasone—hematologic cancer	7.4e-06	3.73e-05	CcSEcCtD
Levofloxacin—Dysgeusia—Epirubicin—hematologic cancer	7.4e-06	3.73e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	7.39e-06	0.000178	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SMPD3—hematologic cancer	7.38e-06	0.000178	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	7.36e-06	0.000178	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Triamcinolone—hematologic cancer	7.35e-06	3.7e-05	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	7.35e-06	0.000177	CbGpPWpGaD
Levofloxacin—Nervousness—Epirubicin—hematologic cancer	7.34e-06	3.7e-05	CcSEcCtD
Levofloxacin—Back pain—Epirubicin—hematologic cancer	7.31e-06	3.68e-05	CcSEcCtD
Levofloxacin—Angiopathy—Doxorubicin—hematologic cancer	7.29e-06	3.67e-05	CcSEcCtD
Levofloxacin—Malaise—Methotrexate—hematologic cancer	7.28e-06	3.67e-05	CcSEcCtD
Levofloxacin—Dizziness—Etoposide—hematologic cancer	7.28e-06	3.66e-05	CcSEcCtD
Levofloxacin—Muscle spasms—Epirubicin—hematologic cancer	7.26e-06	3.66e-05	CcSEcCtD
Levofloxacin—Immune system disorder—Doxorubicin—hematologic cancer	7.25e-06	3.65e-05	CcSEcCtD
Levofloxacin—Vertigo—Methotrexate—hematologic cancer	7.25e-06	3.65e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—CDA—hematologic cancer	7.25e-06	0.000175	CbGpPWpGaD
Levofloxacin—Mediastinal disorder—Doxorubicin—hematologic cancer	7.24e-06	3.64e-05	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.23e-06	0.000175	CbGpPWpGaD
Levofloxacin—Leukopenia—Methotrexate—hematologic cancer	7.23e-06	3.64e-05	CcSEcCtD
Levofloxacin—Chills—Doxorubicin—hematologic cancer	7.21e-06	3.63e-05	CcSEcCtD
Levofloxacin—Urticaria—Dexamethasone—hematologic cancer	7.19e-06	3.62e-05	CcSEcCtD
Levofloxacin—Urticaria—Betamethasone—hematologic cancer	7.19e-06	3.62e-05	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Prednisone—hematologic cancer	7.18e-06	3.62e-05	CcSEcCtD
Levofloxacin—Dizziness—Prednisolone—hematologic cancer	7.18e-06	3.61e-05	CcSEcCtD
Levofloxacin—Arrhythmia—Doxorubicin—hematologic cancer	7.18e-06	3.61e-05	CcSEcCtD
Levofloxacin—Asthenia—Triamcinolone—hematologic cancer	7.16e-06	3.61e-05	CcSEcCtD
Levofloxacin—Abdominal pain—Dexamethasone—hematologic cancer	7.16e-06	3.6e-05	CcSEcCtD
Levofloxacin—Abdominal pain—Betamethasone—hematologic cancer	7.16e-06	3.6e-05	CcSEcCtD
Levofloxacin—Body temperature increased—Betamethasone—hematologic cancer	7.16e-06	3.6e-05	CcSEcCtD
Levofloxacin—Body temperature increased—Dexamethasone—hematologic cancer	7.16e-06	3.6e-05	CcSEcCtD
Levofloxacin—Nausea—Cisplatin—hematologic cancer	7.13e-06	3.59e-05	CcSEcCtD
Levofloxacin—Insomnia—Prednisone—hematologic cancer	7.13e-06	3.59e-05	CcSEcCtD
Levofloxacin—Vision blurred—Epirubicin—hematologic cancer	7.12e-06	3.59e-05	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	7.12e-06	0.000172	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	7.1e-06	0.000171	CbGpPWpGaD
Levofloxacin—Alopecia—Doxorubicin—hematologic cancer	7.1e-06	3.57e-05	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	7.08e-06	0.000171	CbGpPWpGaD
Levofloxacin—Paraesthesia—Prednisone—hematologic cancer	7.08e-06	3.57e-05	CcSEcCtD
Levofloxacin—Pruritus—Triamcinolone—hematologic cancer	7.06e-06	3.55e-05	CcSEcCtD
Levofloxacin—Cough—Methotrexate—hematologic cancer	7.05e-06	3.55e-05	CcSEcCtD
Levofloxacin—Mental disorder—Doxorubicin—hematologic cancer	7.04e-06	3.54e-05	CcSEcCtD
Levofloxacin—Ill-defined disorder—Epirubicin—hematologic cancer	7.01e-06	3.53e-05	CcSEcCtD
Levofloxacin—ABCB1—blood—hematologic cancer	7.01e-06	0.0219	CbGeAlD
Levofloxacin—Vomiting—Etoposide—hematologic cancer	7e-06	3.52e-05	CcSEcCtD
Levofloxacin—Erythema—Doxorubicin—hematologic cancer	6.99e-06	3.52e-05	CcSEcCtD
Levofloxacin—Malnutrition—Doxorubicin—hematologic cancer	6.99e-06	3.52e-05	CcSEcCtD
Levofloxacin—Anaemia—Epirubicin—hematologic cancer	6.98e-06	3.52e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—PC—hematologic cancer	6.98e-06	0.000168	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	6.95e-06	0.000168	CbGpPWpGaD
Levofloxacin—Agitation—Epirubicin—hematologic cancer	6.94e-06	3.5e-05	CcSEcCtD
Levofloxacin—Dyspepsia—Prednisone—hematologic cancer	6.94e-06	3.49e-05	CcSEcCtD
Levofloxacin—Rash—Etoposide—hematologic cancer	6.94e-06	3.49e-05	CcSEcCtD
Levofloxacin—Dermatitis—Etoposide—hematologic cancer	6.93e-06	3.49e-05	CcSEcCtD
Levofloxacin—Headache—Etoposide—hematologic cancer	6.89e-06	3.47e-05	CcSEcCtD
Levofloxacin—Flatulence—Doxorubicin—hematologic cancer	6.89e-06	3.47e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—FHL2—hematologic cancer	6.88e-06	0.000166	CbGpPWpGaD
Levofloxacin—Arthralgia—Methotrexate—hematologic cancer	6.87e-06	3.46e-05	CcSEcCtD
Levofloxacin—Chest pain—Methotrexate—hematologic cancer	6.87e-06	3.46e-05	CcSEcCtD
Levofloxacin—Myalgia—Methotrexate—hematologic cancer	6.87e-06	3.46e-05	CcSEcCtD
Levofloxacin—Tension—Doxorubicin—hematologic cancer	6.86e-06	3.45e-05	CcSEcCtD
Levofloxacin—Decreased appetite—Prednisone—hematologic cancer	6.85e-06	3.45e-05	CcSEcCtD
Levofloxacin—Dysgeusia—Doxorubicin—hematologic cancer	6.85e-06	3.45e-05	CcSEcCtD
Levofloxacin—Rash—Prednisolone—hematologic cancer	6.84e-06	3.45e-05	CcSEcCtD
Levofloxacin—Dermatitis—Prednisolone—hematologic cancer	6.84e-06	3.44e-05	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	6.83e-06	3.44e-05	CcSEcCtD
Levofloxacin—Malaise—Epirubicin—hematologic cancer	6.81e-06	3.43e-05	CcSEcCtD
Levofloxacin—Fatigue—Prednisone—hematologic cancer	6.8e-06	3.42e-05	CcSEcCtD
Levofloxacin—Headache—Prednisolone—hematologic cancer	6.8e-06	3.42e-05	CcSEcCtD
Levofloxacin—Discomfort—Methotrexate—hematologic cancer	6.79e-06	3.42e-05	CcSEcCtD
Levofloxacin—Nervousness—Doxorubicin—hematologic cancer	6.79e-06	3.42e-05	CcSEcCtD
Levofloxacin—Vertigo—Epirubicin—hematologic cancer	6.79e-06	3.42e-05	CcSEcCtD
Levofloxacin—ABCB1—bone marrow—hematologic cancer	6.78e-06	0.0212	CbGeAlD
Levofloxacin—Syncope—Epirubicin—hematologic cancer	6.78e-06	3.41e-05	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	6.78e-06	0.000164	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ALB—hematologic cancer	6.77e-06	0.000163	CbGpPWpGaD
Levofloxacin—Leukopenia—Epirubicin—hematologic cancer	6.76e-06	3.41e-05	CcSEcCtD
Levofloxacin—Back pain—Doxorubicin—hematologic cancer	6.76e-06	3.41e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—AGRN—hematologic cancer	6.75e-06	0.000163	CbGpPWpGaD
Levofloxacin—Constipation—Prednisone—hematologic cancer	6.74e-06	3.4e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—SLC35B2—hematologic cancer	6.74e-06	0.000163	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GBA—hematologic cancer	6.74e-06	0.000163	CbGpPWpGaD
Levofloxacin—Muscle spasms—Doxorubicin—hematologic cancer	6.72e-06	3.38e-05	CcSEcCtD
Levofloxacin—Palpitations—Epirubicin—hematologic cancer	6.68e-06	3.36e-05	CcSEcCtD
Levofloxacin—Confusional state—Methotrexate—hematologic cancer	6.64e-06	3.35e-05	CcSEcCtD
Levofloxacin—Loss of consciousness—Epirubicin—hematologic cancer	6.64e-06	3.34e-05	CcSEcCtD
Levofloxacin—Dizziness—Triamcinolone—hematologic cancer	6.6e-06	3.32e-05	CcSEcCtD
Levofloxacin—Cough—Epirubicin—hematologic cancer	6.59e-06	3.32e-05	CcSEcCtD
Levofloxacin—Anaphylactic shock—Methotrexate—hematologic cancer	6.59e-06	3.32e-05	CcSEcCtD
Levofloxacin—Vision blurred—Doxorubicin—hematologic cancer	6.59e-06	3.32e-05	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	6.59e-06	0.000159	CbGpPWpGaD
Levofloxacin—Infection—Methotrexate—hematologic cancer	6.55e-06	3.3e-05	CcSEcCtD
Levofloxacin—Nausea—Etoposide—hematologic cancer	6.53e-06	3.29e-05	CcSEcCtD
Levofloxacin—Hypertension—Epirubicin—hematologic cancer	6.52e-06	3.28e-05	CcSEcCtD
Levofloxacin—Feeling abnormal—Prednisone—hematologic cancer	6.5e-06	3.27e-05	CcSEcCtD
Levofloxacin—Asthenia—Betamethasone—hematologic cancer	6.5e-06	3.27e-05	CcSEcCtD
Levofloxacin—Asthenia—Dexamethasone—hematologic cancer	6.5e-06	3.27e-05	CcSEcCtD
Levofloxacin—Ill-defined disorder—Doxorubicin—hematologic cancer	6.49e-06	3.27e-05	CcSEcCtD
Levofloxacin—Nervous system disorder—Methotrexate—hematologic cancer	6.46e-06	3.25e-05	CcSEcCtD
Levofloxacin—Anaemia—Doxorubicin—hematologic cancer	6.46e-06	3.25e-05	CcSEcCtD
Levofloxacin—CYP3A4—Metabolism—B3GAT1—hematologic cancer	6.45e-06	0.000156	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ASNS—hematologic cancer	6.45e-06	0.000156	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—DCK—hematologic cancer	6.45e-06	0.000156	CbGpPWpGaD
Levofloxacin—Thrombocytopenia—Methotrexate—hematologic cancer	6.45e-06	3.25e-05	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Prednisone—hematologic cancer	6.45e-06	3.25e-05	CcSEcCtD
Levofloxacin—Nausea—Prednisolone—hematologic cancer	6.45e-06	3.25e-05	CcSEcCtD
Levofloxacin—Arthralgia—Epirubicin—hematologic cancer	6.43e-06	3.24e-05	CcSEcCtD
Levofloxacin—Myalgia—Epirubicin—hematologic cancer	6.43e-06	3.24e-05	CcSEcCtD
Levofloxacin—Chest pain—Epirubicin—hematologic cancer	6.43e-06	3.24e-05	CcSEcCtD
Levofloxacin—Agitation—Doxorubicin—hematologic cancer	6.43e-06	3.24e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—CD44—hematologic cancer	6.42e-06	0.000155	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NQO1—hematologic cancer	6.42e-06	0.000155	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	6.42e-06	0.000155	CbGpPWpGaD
Levofloxacin—Anxiety—Epirubicin—hematologic cancer	6.41e-06	3.23e-05	CcSEcCtD
Levofloxacin—Pruritus—Dexamethasone—hematologic cancer	6.41e-06	3.23e-05	CcSEcCtD
Levofloxacin—Pruritus—Betamethasone—hematologic cancer	6.41e-06	3.23e-05	CcSEcCtD
Levofloxacin—Skin disorder—Methotrexate—hematologic cancer	6.4e-06	3.22e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—IDH2—hematologic cancer	6.4e-06	0.000154	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—HMMR—hematologic cancer	6.4e-06	0.000154	CbGpPWpGaD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	6.39e-06	3.22e-05	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—TP53—hematologic cancer	6.37e-06	0.000154	CbGpPWpGaD
Levofloxacin—Hyperhidrosis—Methotrexate—hematologic cancer	6.37e-06	3.21e-05	CcSEcCtD
Levofloxacin—Discomfort—Epirubicin—hematologic cancer	6.36e-06	3.2e-05	CcSEcCtD
Levofloxacin—Vomiting—Triamcinolone—hematologic cancer	6.34e-06	3.19e-05	CcSEcCtD
Levofloxacin—Malaise—Doxorubicin—hematologic cancer	6.31e-06	3.17e-05	CcSEcCtD
Levofloxacin—Rash—Triamcinolone—hematologic cancer	6.29e-06	3.17e-05	CcSEcCtD
Levofloxacin—Dry mouth—Epirubicin—hematologic cancer	6.29e-06	3.17e-05	CcSEcCtD
Levofloxacin—Dermatitis—Triamcinolone—hematologic cancer	6.29e-06	3.17e-05	CcSEcCtD
Levofloxacin—Vertigo—Doxorubicin—hematologic cancer	6.28e-06	3.16e-05	CcSEcCtD
Levofloxacin—Anorexia—Methotrexate—hematologic cancer	6.28e-06	3.16e-05	CcSEcCtD
Levofloxacin—Syncope—Doxorubicin—hematologic cancer	6.27e-06	3.16e-05	CcSEcCtD
Levofloxacin—SLC22A2—Neuronal System—HRAS—hematologic cancer	6.27e-06	0.000151	CbGpPWpGaD
Levofloxacin—Urticaria—Prednisone—hematologic cancer	6.26e-06	3.15e-05	CcSEcCtD
Levofloxacin—Leukopenia—Doxorubicin—hematologic cancer	6.26e-06	3.15e-05	CcSEcCtD
Levofloxacin—Headache—Triamcinolone—hematologic cancer	6.25e-06	3.15e-05	CcSEcCtD
Levofloxacin—Abdominal pain—Prednisone—hematologic cancer	6.23e-06	3.14e-05	CcSEcCtD
Levofloxacin—Body temperature increased—Prednisone—hematologic cancer	6.23e-06	3.14e-05	CcSEcCtD
Levofloxacin—Confusional state—Epirubicin—hematologic cancer	6.22e-06	3.13e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Betamethasone—hematologic cancer	6.2e-06	3.12e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Dexamethasone—hematologic cancer	6.2e-06	3.12e-05	CcSEcCtD
Levofloxacin—Palpitations—Doxorubicin—hematologic cancer	6.18e-06	3.11e-05	CcSEcCtD
Levofloxacin—Anaphylactic shock—Epirubicin—hematologic cancer	6.17e-06	3.11e-05	CcSEcCtD
Levofloxacin—Oedema—Epirubicin—hematologic cancer	6.17e-06	3.11e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—MTAP—hematologic cancer	6.16e-06	0.000149	CbGpPWpGaD
Levofloxacin—Hypotension—Methotrexate—hematologic cancer	6.16e-06	3.1e-05	CcSEcCtD
Levofloxacin—Loss of consciousness—Doxorubicin—hematologic cancer	6.15e-06	3.09e-05	CcSEcCtD
Levofloxacin—ABCB1—lung—hematologic cancer	6.14e-06	0.0192	CbGeAlD
Levofloxacin—Infection—Epirubicin—hematologic cancer	6.13e-06	3.08e-05	CcSEcCtD
Levofloxacin—CYP3A4—Metabolism—HDC—hematologic cancer	6.12e-06	0.000148	CbGpPWpGaD
Levofloxacin—Cough—Doxorubicin—hematologic cancer	6.1e-06	3.07e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—CYCS—hematologic cancer	6.07e-06	0.000147	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	6.07e-06	0.000147	CbGpPWpGaD
Levofloxacin—Shock—Epirubicin—hematologic cancer	6.07e-06	3.06e-05	CcSEcCtD
Levofloxacin—Nervous system disorder—Epirubicin—hematologic cancer	6.05e-06	3.05e-05	CcSEcCtD
Levofloxacin—Thrombocytopenia—Epirubicin—hematologic cancer	6.04e-06	3.04e-05	CcSEcCtD
Levofloxacin—Hypertension—Doxorubicin—hematologic cancer	6.04e-06	3.04e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—HSP90AA1—hematologic cancer	6.03e-06	0.000146	CbGpPWpGaD
Levofloxacin—Tachycardia—Epirubicin—hematologic cancer	6.02e-06	3.03e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—ARNTL—hematologic cancer	6.02e-06	0.000145	CbGpPWpGaD
Levofloxacin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	6e-06	3.02e-05	CcSEcCtD
Levofloxacin—Skin disorder—Epirubicin—hematologic cancer	5.99e-06	3.02e-05	CcSEcCtD
Levofloxacin—Dizziness—Dexamethasone—hematologic cancer	5.99e-06	3.01e-05	CcSEcCtD
Levofloxacin—Dizziness—Betamethasone—hematologic cancer	5.99e-06	3.01e-05	CcSEcCtD
Levofloxacin—Hyperhidrosis—Epirubicin—hematologic cancer	5.96e-06	3e-05	CcSEcCtD
Levofloxacin—Insomnia—Methotrexate—hematologic cancer	5.96e-06	3e-05	CcSEcCtD
Levofloxacin—Chest pain—Doxorubicin—hematologic cancer	5.95e-06	3e-05	CcSEcCtD
Levofloxacin—Myalgia—Doxorubicin—hematologic cancer	5.95e-06	3e-05	CcSEcCtD
Levofloxacin—Arthralgia—Doxorubicin—hematologic cancer	5.95e-06	3e-05	CcSEcCtD
Levofloxacin—Anxiety—Doxorubicin—hematologic cancer	5.93e-06	2.99e-05	CcSEcCtD
Levofloxacin—Nausea—Triamcinolone—hematologic cancer	5.93e-06	2.98e-05	CcSEcCtD
Levofloxacin—Paraesthesia—Methotrexate—hematologic cancer	5.92e-06	2.98e-05	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	5.91e-06	2.98e-05	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	5.9e-06	0.000143	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	5.89e-06	0.000142	CbGpPWpGaD
Levofloxacin—Discomfort—Doxorubicin—hematologic cancer	5.88e-06	2.96e-05	CcSEcCtD
Levofloxacin—Anorexia—Epirubicin—hematologic cancer	5.88e-06	2.96e-05	CcSEcCtD
Levofloxacin—Dyspnoea—Methotrexate—hematologic cancer	5.88e-06	2.96e-05	CcSEcCtD
Levofloxacin—Somnolence—Methotrexate—hematologic cancer	5.86e-06	2.95e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—ACP5—hematologic cancer	5.85e-06	0.000141	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CA9—hematologic cancer	5.85e-06	0.000141	CbGpPWpGaD
Levofloxacin—Dry mouth—Doxorubicin—hematologic cancer	5.82e-06	2.93e-05	CcSEcCtD
Levofloxacin—Hypersensitivity—Prednisone—hematologic cancer	5.81e-06	2.93e-05	CcSEcCtD
Levofloxacin—Dyspepsia—Methotrexate—hematologic cancer	5.8e-06	2.92e-05	CcSEcCtD
Levofloxacin—ABCB1—testis—hematologic cancer	5.8e-06	0.0181	CbGeAlD
Levofloxacin—ABCB1—Metabolism—NCOR2—hematologic cancer	5.78e-06	0.000139	CbGpPWpGaD
Levofloxacin—Hypotension—Epirubicin—hematologic cancer	5.76e-06	2.9e-05	CcSEcCtD
Levofloxacin—Vomiting—Betamethasone—hematologic cancer	5.76e-06	2.9e-05	CcSEcCtD
Levofloxacin—Vomiting—Dexamethasone—hematologic cancer	5.76e-06	2.9e-05	CcSEcCtD
Levofloxacin—Confusional state—Doxorubicin—hematologic cancer	5.75e-06	2.9e-05	CcSEcCtD
Levofloxacin—Decreased appetite—Methotrexate—hematologic cancer	5.73e-06	2.88e-05	CcSEcCtD
Levofloxacin—Rash—Dexamethasone—hematologic cancer	5.71e-06	2.87e-05	CcSEcCtD
Levofloxacin—Rash—Betamethasone—hematologic cancer	5.71e-06	2.87e-05	CcSEcCtD
Levofloxacin—Anaphylactic shock—Doxorubicin—hematologic cancer	5.71e-06	2.87e-05	CcSEcCtD
Levofloxacin—Oedema—Doxorubicin—hematologic cancer	5.71e-06	2.87e-05	CcSEcCtD
Levofloxacin—Dermatitis—Betamethasone—hematologic cancer	5.7e-06	2.87e-05	CcSEcCtD
Levofloxacin—Dermatitis—Dexamethasone—hematologic cancer	5.7e-06	2.87e-05	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.69e-06	2.86e-05	CcSEcCtD
Levofloxacin—Fatigue—Methotrexate—hematologic cancer	5.68e-06	2.86e-05	CcSEcCtD
Levofloxacin—Headache—Dexamethasone—hematologic cancer	5.67e-06	2.86e-05	CcSEcCtD
Levofloxacin—Headache—Betamethasone—hematologic cancer	5.67e-06	2.86e-05	CcSEcCtD
Levofloxacin—Infection—Doxorubicin—hematologic cancer	5.67e-06	2.85e-05	CcSEcCtD
Levofloxacin—Asthenia—Prednisone—hematologic cancer	5.66e-06	2.85e-05	CcSEcCtD
Levofloxacin—Pain—Methotrexate—hematologic cancer	5.64e-06	2.84e-05	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.62e-06	2.83e-05	CcSEcCtD
Levofloxacin—Shock—Doxorubicin—hematologic cancer	5.61e-06	2.83e-05	CcSEcCtD
Levofloxacin—Nervous system disorder—Doxorubicin—hematologic cancer	5.6e-06	2.82e-05	CcSEcCtD
Levofloxacin—CYP3A4—Metabolism—CDA—hematologic cancer	5.6e-06	0.000135	CbGpPWpGaD
Levofloxacin—Thrombocytopenia—Doxorubicin—hematologic cancer	5.59e-06	2.81e-05	CcSEcCtD
Levofloxacin—Pruritus—Prednisone—hematologic cancer	5.58e-06	2.81e-05	CcSEcCtD
Levofloxacin—Insomnia—Epirubicin—hematologic cancer	5.58e-06	2.81e-05	CcSEcCtD
Levofloxacin—Tachycardia—Doxorubicin—hematologic cancer	5.57e-06	2.8e-05	CcSEcCtD
Levofloxacin—Skin disorder—Doxorubicin—hematologic cancer	5.54e-06	2.79e-05	CcSEcCtD
Levofloxacin—Paraesthesia—Epirubicin—hematologic cancer	5.54e-06	2.79e-05	CcSEcCtD
Levofloxacin—Hyperhidrosis—Doxorubicin—hematologic cancer	5.52e-06	2.78e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—IDH1—hematologic cancer	5.5e-06	0.000133	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	5.5e-06	0.000133	CbGpPWpGaD
Levofloxacin—Dyspnoea—Epirubicin—hematologic cancer	5.5e-06	2.77e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—FHL2—hematologic cancer	5.49e-06	0.000133	CbGpPWpGaD
Levofloxacin—Somnolence—Epirubicin—hematologic cancer	5.48e-06	2.76e-05	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	5.46e-06	0.000132	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—TXN—hematologic cancer	5.44e-06	0.000131	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ABCC3—hematologic cancer	5.44e-06	0.000131	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTO1—hematologic cancer	5.44e-06	0.000131	CbGpPWpGaD
Levofloxacin—Anorexia—Doxorubicin—hematologic cancer	5.44e-06	2.74e-05	CcSEcCtD
Levofloxacin—Feeling abnormal—Methotrexate—hematologic cancer	5.43e-06	2.73e-05	CcSEcCtD
Levofloxacin—Dyspepsia—Epirubicin—hematologic cancer	5.43e-06	2.73e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Prednisone—hematologic cancer	5.4e-06	2.72e-05	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Methotrexate—hematologic cancer	5.39e-06	2.71e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—AGRN—hematologic cancer	5.39e-06	0.00013	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PC—hematologic cancer	5.39e-06	0.00013	CbGpPWpGaD
Levofloxacin—Nausea—Betamethasone—hematologic cancer	5.38e-06	2.71e-05	CcSEcCtD
Levofloxacin—Nausea—Dexamethasone—hematologic cancer	5.38e-06	2.71e-05	CcSEcCtD
Levofloxacin—Decreased appetite—Epirubicin—hematologic cancer	5.36e-06	2.7e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—GSTP1—hematologic cancer	5.35e-06	0.000129	CbGpPWpGaD
Levofloxacin—Hypotension—Doxorubicin—hematologic cancer	5.33e-06	2.68e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—SPHK1—hematologic cancer	5.32e-06	0.000129	CbGpPWpGaD
Levofloxacin—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.32e-06	2.68e-05	CcSEcCtD
Levofloxacin—Fatigue—Epirubicin—hematologic cancer	5.32e-06	2.68e-05	CcSEcCtD
Levofloxacin—Constipation—Epirubicin—hematologic cancer	5.27e-06	2.66e-05	CcSEcCtD
Levofloxacin—Pain—Epirubicin—hematologic cancer	5.27e-06	2.66e-05	CcSEcCtD
Levofloxacin—Urticaria—Methotrexate—hematologic cancer	5.24e-06	2.64e-05	CcSEcCtD
Levofloxacin—Dizziness—Prednisone—hematologic cancer	5.21e-06	2.63e-05	CcSEcCtD
Levofloxacin—Abdominal pain—Methotrexate—hematologic cancer	5.21e-06	2.62e-05	CcSEcCtD
Levofloxacin—Body temperature increased—Methotrexate—hematologic cancer	5.21e-06	2.62e-05	CcSEcCtD
Levofloxacin—CYP3A4—Metabolism—GBA—hematologic cancer	5.2e-06	0.000126	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.2e-06	0.000126	CbGpPWpGaD
Levofloxacin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.2e-06	2.62e-05	CcSEcCtD
Levofloxacin—Insomnia—Doxorubicin—hematologic cancer	5.16e-06	2.6e-05	CcSEcCtD
Levofloxacin—Paraesthesia—Doxorubicin—hematologic cancer	5.12e-06	2.58e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—UGT1A1—hematologic cancer	5.12e-06	0.000123	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—IDH2—hematologic cancer	5.11e-06	0.000123	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—HMMR—hematologic cancer	5.11e-06	0.000123	CbGpPWpGaD
Levofloxacin—Dyspnoea—Doxorubicin—hematologic cancer	5.09e-06	2.56e-05	CcSEcCtD
Levofloxacin—Feeling abnormal—Epirubicin—hematologic cancer	5.08e-06	2.56e-05	CcSEcCtD
Levofloxacin—Somnolence—Doxorubicin—hematologic cancer	5.07e-06	2.55e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—ABCB1—hematologic cancer	5.07e-06	0.000122	CbGpPWpGaD
Levofloxacin—Gastrointestinal pain—Epirubicin—hematologic cancer	5.04e-06	2.54e-05	CcSEcCtD
Levofloxacin—Dyspepsia—Doxorubicin—hematologic cancer	5.02e-06	2.53e-05	CcSEcCtD
Levofloxacin—Vomiting—Prednisone—hematologic cancer	5.01e-06	2.52e-05	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	5.01e-06	0.000121	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.98e-06	0.00012	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CRABP1—hematologic cancer	4.98e-06	0.00012	CbGpPWpGaD
Levofloxacin—Rash—Prednisone—hematologic cancer	4.97e-06	2.5e-05	CcSEcCtD
Levofloxacin—Dermatitis—Prednisone—hematologic cancer	4.97e-06	2.5e-05	CcSEcCtD
Levofloxacin—Decreased appetite—Doxorubicin—hematologic cancer	4.96e-06	2.5e-05	CcSEcCtD
Levofloxacin—Headache—Prednisone—hematologic cancer	4.94e-06	2.49e-05	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.93e-06	2.48e-05	CcSEcCtD
Levofloxacin—Fatigue—Doxorubicin—hematologic cancer	4.92e-06	2.48e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—GSTM1—hematologic cancer	4.92e-06	0.000119	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NCOR1—hematologic cancer	4.92e-06	0.000119	CbGpPWpGaD
Levofloxacin—Urticaria—Epirubicin—hematologic cancer	4.9e-06	2.47e-05	CcSEcCtD
Levofloxacin—Constipation—Doxorubicin—hematologic cancer	4.88e-06	2.46e-05	CcSEcCtD
Levofloxacin—Pain—Doxorubicin—hematologic cancer	4.88e-06	2.46e-05	CcSEcCtD
Levofloxacin—Body temperature increased—Epirubicin—hematologic cancer	4.88e-06	2.45e-05	CcSEcCtD
Levofloxacin—Abdominal pain—Epirubicin—hematologic cancer	4.88e-06	2.45e-05	CcSEcCtD
Levofloxacin—Hypersensitivity—Methotrexate—hematologic cancer	4.86e-06	2.44e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—ALOX5—hematologic cancer	4.85e-06	0.000117	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.85e-06	0.000117	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	4.82e-06	0.000116	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ARNTL—hematologic cancer	4.8e-06	0.000116	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—MTAP—hematologic cancer	4.76e-06	0.000115	CbGpPWpGaD
Levofloxacin—Asthenia—Methotrexate—hematologic cancer	4.73e-06	2.38e-05	CcSEcCtD
Levofloxacin—Feeling abnormal—Doxorubicin—hematologic cancer	4.7e-06	2.37e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—NUP98—hematologic cancer	4.7e-06	0.000113	CbGpPWpGaD
Levofloxacin—Nausea—Prednisone—hematologic cancer	4.68e-06	2.36e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—ACP5—hematologic cancer	4.67e-06	0.000113	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CA9—hematologic cancer	4.67e-06	0.000113	CbGpPWpGaD
Levofloxacin—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.67e-06	2.35e-05	CcSEcCtD
Levofloxacin—Pruritus—Methotrexate—hematologic cancer	4.66e-06	2.35e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—NCOR2—hematologic cancer	4.61e-06	0.000111	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ADCY7—hematologic cancer	4.56e-06	0.00011	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NCOA3—hematologic cancer	4.56e-06	0.00011	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Epirubicin—hematologic cancer	4.54e-06	2.29e-05	CcSEcCtD
Levofloxacin—Urticaria—Doxorubicin—hematologic cancer	4.53e-06	2.28e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—NUP214—hematologic cancer	4.53e-06	0.000109	CbGpPWpGaD
Levofloxacin—Abdominal pain—Doxorubicin—hematologic cancer	4.51e-06	2.27e-05	CcSEcCtD
Levofloxacin—Body temperature increased—Doxorubicin—hematologic cancer	4.51e-06	2.27e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Methotrexate—hematologic cancer	4.51e-06	2.27e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—ABCG2—hematologic cancer	4.44e-06	0.000107	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—MTR—hematologic cancer	4.44e-06	0.000107	CbGpPWpGaD
Levofloxacin—Asthenia—Epirubicin—hematologic cancer	4.42e-06	2.23e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—IDH1—hematologic cancer	4.39e-06	0.000106	CbGpPWpGaD
Levofloxacin—Pruritus—Epirubicin—hematologic cancer	4.36e-06	2.2e-05	CcSEcCtD
Levofloxacin—Dizziness—Methotrexate—hematologic cancer	4.36e-06	2.19e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—ENO2—hematologic cancer	4.35e-06	0.000105	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—MTHFR—hematologic cancer	4.35e-06	0.000105	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—TXN—hematologic cancer	4.34e-06	0.000105	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.34e-06	0.000105	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.34e-06	0.000105	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.25e-06	0.000103	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—FHL2—hematologic cancer	4.24e-06	0.000102	CbGpPWpGaD
Levofloxacin—Diarrhoea—Epirubicin—hematologic cancer	4.22e-06	2.12e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—GSTT1—hematologic cancer	4.22e-06	0.000102	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Doxorubicin—hematologic cancer	4.2e-06	2.12e-05	CcSEcCtD
Levofloxacin—ABCB1—lymph node—hematologic cancer	4.2e-06	0.0131	CbGeAlD
Levofloxacin—Vomiting—Methotrexate—hematologic cancer	4.19e-06	2.11e-05	CcSEcCtD
Levofloxacin—CYP3A4—Metabolism—AGRN—hematologic cancer	4.16e-06	0.0001	CbGpPWpGaD
Levofloxacin—Rash—Methotrexate—hematologic cancer	4.16e-06	2.09e-05	CcSEcCtD
Levofloxacin—Dermatitis—Methotrexate—hematologic cancer	4.15e-06	2.09e-05	CcSEcCtD
Levofloxacin—Headache—Methotrexate—hematologic cancer	4.13e-06	2.08e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—SDC1—hematologic cancer	4.12e-06	9.95e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.09e-06	9.88e-05	CbGpPWpGaD
Levofloxacin—Asthenia—Doxorubicin—hematologic cancer	4.09e-06	2.06e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.08e-06	9.86e-05	CbGpPWpGaD
Levofloxacin—Dizziness—Epirubicin—hematologic cancer	4.08e-06	2.05e-05	CcSEcCtD
Levofloxacin—Pruritus—Doxorubicin—hematologic cancer	4.04e-06	2.03e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—CRABP1—hematologic cancer	3.97e-06	9.59e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC22A1—hematologic cancer	3.97e-06	9.59e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.95e-06	9.53e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—IDH2—hematologic cancer	3.94e-06	9.52e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—HMMR—hematologic cancer	3.94e-06	9.52e-05	CbGpPWpGaD
Levofloxacin—Vomiting—Epirubicin—hematologic cancer	3.92e-06	1.97e-05	CcSEcCtD
Levofloxacin—Nausea—Methotrexate—hematologic cancer	3.91e-06	1.97e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Doxorubicin—hematologic cancer	3.9e-06	1.97e-05	CcSEcCtD
Levofloxacin—Rash—Epirubicin—hematologic cancer	3.89e-06	1.96e-05	CcSEcCtD
Levofloxacin—Dermatitis—Epirubicin—hematologic cancer	3.88e-06	1.96e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.87e-06	9.34e-05	CbGpPWpGaD
Levofloxacin—Headache—Epirubicin—hematologic cancer	3.86e-06	1.95e-05	CcSEcCtD
Levofloxacin—Dizziness—Doxorubicin—hematologic cancer	3.77e-06	1.9e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—NUP98—hematologic cancer	3.75e-06	9.05e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.71e-06	8.95e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.7e-06	8.92e-05	CbGpPWpGaD
Levofloxacin—Nausea—Epirubicin—hematologic cancer	3.66e-06	1.84e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—PIK3CG—hematologic cancer	3.65e-06	8.82e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.64e-06	8.79e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.64e-06	8.79e-05	CbGpPWpGaD
Levofloxacin—Vomiting—Doxorubicin—hematologic cancer	3.63e-06	1.83e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—NUP214—hematologic cancer	3.61e-06	8.72e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ACP5—hematologic cancer	3.61e-06	8.7e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CA9—hematologic cancer	3.61e-06	8.7e-05	CbGpPWpGaD
Levofloxacin—Rash—Doxorubicin—hematologic cancer	3.6e-06	1.81e-05	CcSEcCtD
Levofloxacin—Dermatitis—Doxorubicin—hematologic cancer	3.59e-06	1.81e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.58e-06	8.63e-05	CbGpPWpGaD
Levofloxacin—Headache—Doxorubicin—hematologic cancer	3.57e-06	1.8e-05	CcSEcCtD
Levofloxacin—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.56e-06	8.59e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—MTR—hematologic cancer	3.54e-06	8.55e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.54e-06	8.55e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NQO1—hematologic cancer	3.51e-06	8.46e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CD44—hematologic cancer	3.51e-06	8.46e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ENO2—hematologic cancer	3.47e-06	8.38e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—IDH1—hematologic cancer	3.39e-06	8.18e-05	CbGpPWpGaD
Levofloxacin—Nausea—Doxorubicin—hematologic cancer	3.39e-06	1.71e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—CREBBP—hematologic cancer	3.39e-06	8.17e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.37e-06	8.13e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.35e-06	8.09e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—TXN—hematologic cancer	3.35e-06	8.09e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.35e-06	8.09e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYCS—hematologic cancer	3.32e-06	8.01e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.32e-06	8e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.3e-06	7.96e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SDC1—hematologic cancer	3.29e-06	7.95e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.28e-06	7.92e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CD—hematologic cancer	3.21e-06	7.75e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ALB—hematologic cancer	3.17e-06	7.65e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.15e-06	7.61e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.14e-06	7.59e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.1e-06	7.49e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.07e-06	7.4e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.07e-06	7.4e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3R1—hematologic cancer	3.03e-06	7.32e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.99e-06	7.21e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.97e-06	7.17e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTP1—hematologic cancer	2.92e-06	7.06e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NUP98—hematologic cancer	2.89e-06	6.98e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.81e-06	6.78e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.81e-06	6.78e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CD44—hematologic cancer	2.8e-06	6.76e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NQO1—hematologic cancer	2.8e-06	6.76e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CB—hematologic cancer	2.8e-06	6.76e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NUP214—hematologic cancer	2.79e-06	6.73e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.74e-06	6.62e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—MTR—hematologic cancer	2.73e-06	6.6e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.73e-06	6.6e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTM1—hematologic cancer	2.69e-06	6.49e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NCOR1—hematologic cancer	2.69e-06	6.49e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ENO2—hematologic cancer	2.68e-06	6.47e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYCS—hematologic cancer	2.65e-06	6.39e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.63e-06	6.35e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.6e-06	6.27e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SDC1—hematologic cancer	2.54e-06	6.13e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTEN—hematologic cancer	2.42e-06	5.84e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—MTHFR—hematologic cancer	2.37e-06	5.73e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.37e-06	5.72e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.33e-06	5.63e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—EP300—hematologic cancer	2.31e-06	5.57e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.26e-06	5.45e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.21e-06	5.33e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CD44—hematologic cancer	2.16e-06	5.21e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NQO1—hematologic cancer	2.16e-06	5.21e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.15e-06	5.18e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.15e-06	5.18e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYCS—hematologic cancer	2.04e-06	4.93e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.03e-06	4.9e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CG—hematologic cancer	2e-06	4.82e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.9e-06	4.58e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CREBBP—hematologic cancer	1.85e-06	4.47e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.8e-06	4.35e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.75e-06	4.23e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALB—hematologic cancer	1.73e-06	4.18e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CA—hematologic cancer	1.71e-06	4.12e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.71e-06	4.12e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.67e-06	4.03e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.66e-06	4e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.66e-06	4e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.66e-06	4e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.59e-06	3.84e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.53e-06	3.69e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.48e-06	3.56e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.46e-06	3.53e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.4e-06	3.38e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—AKT1—hematologic cancer	1.39e-06	3.36e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALB—hematologic cancer	1.38e-06	3.34e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.32e-06	3.19e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTEN—hematologic cancer	1.32e-06	3.19e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—EP300—hematologic cancer	1.26e-06	3.04e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.23e-06	2.97e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.22e-06	2.95e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.14e-06	2.75e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.08e-06	2.61e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALB—hematologic cancer	1.07e-06	2.58e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTEN—hematologic cancer	1.05e-06	2.55e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.02e-06	2.46e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—EP300—hematologic cancer	1.01e-06	2.43e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.42e-07	2.27e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CA—hematologic cancer	9.32e-07	2.25e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTEN—hematologic cancer	8.14e-07	1.96e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—EP300—hematologic cancer	7.76e-07	1.87e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—AKT1—hematologic cancer	7.61e-07	1.84e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.44e-07	1.8e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—AKT1—hematologic cancer	6.08e-07	1.47e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.74e-07	1.39e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AKT1—hematologic cancer	4.69e-07	1.13e-05	CbGpPWpGaD
